Adhera Therapeutics Signs Letter Of Intent To Acquire CD71-Targeted Cancer Therapy Paclitaxel Gallium Transferrin >ATRX
Adhera Therapeutics Signs Letter Of Intent To Acquire CD71-Targeted Cancer Therapy Paclitaxel Gallium Transferrin >ATRX
Adhera Therapeutics 签署收购 CD71 靶向癌症疗法的意向书 paclitaxel 镓转铁蛋白 >ATRX
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册